(Q35238870)

English

What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

0 references

Martha K Terris

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Anna E Teeter

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Lionel L Bañez

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Joseph C Presti

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

William J Aronson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Christopher J Kane

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Christopher L Amling

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Stephen J Freedland

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

SEARCH Database Group

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

0 references

publication date

17 September 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Journal of Urology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

180

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1980-4; discussion 1985

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

13 July 2018

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

13 July 2018

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

13 July 2018

Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

13 July 2018

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

13 July 2018

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

13 July 2018

Pathologic findings at radical prostatectomy: risk factors for failure and death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

26 September 2018

Characterization of biochemical recurrence after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

26 September 2018

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

26 September 2018

Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

26 September 2018

Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

26 September 2018

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

26 September 2018

Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3182520

24 October 2018

Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml

1 reference

https://pubmed.ncbi.nlm.nih.gov/18801519

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of prostatic carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18801519

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifying patients at risk for significant versus clinically insignificant postoperative prostate-specific antigen failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18801519

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The PSA Era is not Over for Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18801519

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/18801519

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02

1 reference

https://pubmed.ncbi.nlm.nih.gov/18801519

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/18801519

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JURO.2008.07.031

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18801519%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35238870&oldid=1597138385"